drugset / Trial / NCT01263080
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
RandomizedFactorialDouble-blindTreatment
Summary
Multicentre randomised double-blind, placebo-controlled 2x2 factorial trial investigating the effects of adding mirtazapine and folic acid to existing therapy for patients with schizophrenia
Timeline
- Start
- 2010-11
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirtazapine | Other / unclassified | 30 mg | — |
| Comparator | folic acid | Other / unclassified | 0.4 mg | — |